Formycon AG (0W4N.L)

EUR 53.2

(0.95%)

Revenue Summary of Formycon AG

  • Formycon AG's latest annual revenue in 2023 was 77.69 Million EUR , up 82.83% from previous year.
  • Formycon AG's latest quarterly revenue in 2024 Q2 was 26.89 Million EUR , down 0.0% from previous quarter.
  • Formycon AG reported a annual revenue of 42.49 Million EUR in annual revenue 2022, up 16.07% from previous year.
  • Formycon AG reported a annual revenue of 36.61 Million EUR in annual revenue 2021, up 6.97% from previous year.
  • Formycon AG reported a quarterly revenue of 33.9 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Formycon AG reported a quarterly revenue of 77.69 Million EUR for 2023 FY, up 82.83% from previous quarter.

Annual Revenue Chart of Formycon AG (2023 - 2009)

Historical Annual Revenue of Formycon AG (2023 - 2009)

Year Revenue Revenue Growth
2023 77.69 Million EUR 82.83%
2022 42.49 Million EUR 16.07%
2021 36.61 Million EUR 6.97%
2020 34.22 Million EUR 3.23%
2019 33.15 Million EUR -22.88%
2018 42.99 Million EUR 48.24%
2017 29 Million EUR 48.48%
2016 19.53 Million EUR 15.41%
2015 16.92 Million EUR 34.49%
2014 12.58 Million EUR 4456.93%
2013 276.17 Thousand EUR 99.5%
2012 138.43 Thousand EUR 0.0%
2011 - EUR -100.0%
2010 49.25 Thousand EUR 146.26%
2009 20 Thousand EUR 0.0%

Peer Revenue Comparison of Formycon AG

Name Revenue Revenue Difference
Boiron SA 493.24 Million EUR 84.248%
Laboratorios Farmaceuticos Rovi, S.A. 829.5 Million EUR 90.633%
Vetoquinol SA 529.27 Million EUR 85.32%
Valneva SE 153.71 Million EUR 49.454%
AB Science S.A. 970 Thousand EUR -7909.897%
Nanobiotix S.A. 30.05 Million EUR -158.487%
PHAXIAM Therapeutics S.A. 1.32 Million EUR -5759.427%
Vivoryon Therapeutics N.V. -3.62 Million EUR 2246.298%
BioSenic S.A. 543 Thousand EUR -14208.656%
ABIVAX Société Anonyme 4.62 Million EUR -1581.368%